Compounded medications referenced in this article - including compounded semaglutide and compounded tirzepatide - are not FDA-approved finished drug products and have not been reviewed by the FDA for safety, effectiveness, or quality before marketing
Your weight loss journey is a transformative experience that deserves dedicated guidance, expert support, and innovative solutions
SeekPeptides provides its members with evidence-based protocols, personalized guidance, and a community of thousands who have navigated these exact injection concerns on their way to successful outcomes
The result is a medication tailored to support your body during the weight loss journey, not just one that suppresses appetite
doi: 10.2147/NSS.S163071
Dosing and Administration Wegovy is administered as a once-weekly subcutaneous injection, typically starting at a lower dose of 0.25 mg, which can be gradually increased based on individual needs and tolerability